(Q42748191)

6 November 2017

0 references

Breast cancer genome heterogeneity: a challenge to personalised medicine? (English)

1 reference

6 November 2017

1 reference

Charles Swanton

1

0 references

P. Andrew Futreal

series ordinal

3

object named as

P Andrew Futreal

1 reference

6 November 2017

Rebecca A Burrell

2

1 reference

6 November 2017

1 February 2011

1 reference

6 November 2017

Breast Cancer Research

1 reference

6 November 2017

13

1 reference

6 November 2017

1

1 reference

6 November 2017

104

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr2807

6 November 2017

0 references

cites work

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Genome remodelling in a basal-like breast cancer metastasis and xenograft

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Complex landscapes of somatic rearrangement in human breast cancer genomes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Inferring tumor progression from genomic heterogeneity

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

Effects of aneuploidy on cellular physiology and cell division in haploid yeast

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

The price of innovation: new estimates of drug development costs

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109569

27 May 2018

Identifiers

DOI

10.1186/BCR2807

1 reference

PMC publication ID

3109569

Dimensions Publication ID

6 November 2017

0 references

1 reference

PMC publication ID

3109569

6 November 2017

PubMed publication ID

21345264

1 reference

PMC publication ID

3109569